Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Oral bicalutamide is safe and effective for female hair loss.

Dupilumab can cause rare side effects like a rash on the face and neck.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

New drug delivery systems improve treatment effectiveness and patient experience.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Dupilumab for eczema may cause hair loss.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Zusanli acupoint injection of metoclopramide effectively treats functional dyspepsia.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Upadacitinib may cause hair loss.

Flutamide, delivered by solid lipid nanoparticles, could potentially treat hair loss.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Dupilumab may cause hair loss, so patients should be monitored.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.